Gillette Fusion Power launches GameFace competition with Brady Quinn
BOSTON Gillette Fusion Power, a Procter & Gamble brand, and football star Brady Quinn are encouraging college guys to compete for the chance to win face time with Quinn via a new GameFace Sweepstakes.
To participate, guys should visit www.gillettegameface.com where they will be directed to join the Gillette GameFace Group on Facebook and to check out Quinn’s GameFace video with advice on how to create their own. Second, they create a video or photo that showcases their own GameFace ritual and upload it.
Those who upload photos or videos automatically will be entered in a weekly drawing. Each week throughout the sweepstakes, three winners will be chosen randomly. They will receive a Gillette Fusion shave kit, a MiniDV Digital Camcorder and a Quinn autographed football. The grand prize is an all-inclusive trip for four to New York City to meet Quinn, and a Gillette GameFace entertainment package.
The contest ends Dec. 3, 2007.
Guys also can create videos at the Gillette Fusion Power GameFace College Tour exhibition, on site at each ESPN College GameDay live broadcast location and at the ESPN GridIron Blowout tour events.
Lornamead announces additions to senior management
STAMFORD, Conn. Personal care company Lornamead, whose brands include Finesse and Aqua Net, has announced additions to its senior management team.
David Melagrano has been named vice president of finance for the company’s Stamford-based North and South American operations. Pete Columbia has been named vice president of sales.
Melagrano has spent the majority of his career at Bristol-Myers Squibb, where he held roles in finance, accounting and information technology. He also worked at Cadbury Schweppes in financial planning and analysis and commercial finance supporting new product introductions.
Prior to joining Lornamead, Columbia served as senior vice president of sales and marketing with White Rain Co., where he helped with the relaunch of the White Rain hair care brand. Before that he held sales and marketing positions with Andrew Jergens Co. and Helene Curtis/Unilever.
Hi-Tech announces FDA approval of its generic Penlac
AMITYVILLE, N.Y. Hi-Tech Pharmaceuticals has received final approval from the Food and Drug Administration for its application for the generic version of Dermik Laboratories’ topical nail fungus treatment drug Penlac.
Hi-Tech is a specialty pharmaceutical company that develops, manufactures, and markets brand and generic prescriptions and over-the-counter products for the healthcare industry.
Penlac had sales of $87 million in 2006, according to IMS sales data.